Trial Profile
A retrospective study to evaluate the effectiveness of Ceftolozane/Tazobactam in treating multi drug resistant Pseudomonas aeruginosa infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
- 30 Sep 2016 New trial record